The FDA approved a new DARZALEX FASPRO combination therapy for newly diagnosed multiple myeloma patients who are not eligible ...

Multiple Myeloma (MM) research is at the forefront of personalized medicine, driven by rapid advancements in laboratory genomics and molecular diagnostics.

Johnson & Johnson’s Darzalex Faspro-based quadruplet regimen approved in US for newly diagnosed patients with multiple myeloma who are transplant ineligible: Horsham, Pennsylvan ...

The International Myeloma Foundation (IMF) today welcomed Stephen L. Houff, MD, as the newest member of the IMF Board of ...

Darzalex Faspro is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic ...

GiveByCruising by Dream Vacations is proudly partnering with Blood Cancer United® (formerly The Leukemia & Lymphoma Society) ...

Thusday morning, Thermo Fisher Scientific, which has a laboratory in Center Valley and also an Allentown location, reported ...

Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...

Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to the Thermo Fisher ...

A KIND-HEARTED team of carers who helped a woman through "the worst year of my life" are set to be celebrated at a 'bonkers bingo' night.

Group sales grew by 7%1 at constant exchange rates (CER; 2% in CHF), driven by strong demand for medicines and diagnostic solutions.Sales in the fourth quarter increased by 8%, reflecting the positive ...